Additional file 1 of Clinical implications of circulating tumor DNA in predicting the outcome of diffuse large B cell lymphoma patients receiving first-line therapy
Description
Additional file 1: Table S1. Gene list of Onco-LymScan panel. Table S2. Overview of patient characteristics. Table S3. Demographic of patient characteristics. Table S4. Sequencing quality data of tumor gDNA samples. Table S5. Sequencing quality data of cfDNA samples. Table S6. Univariate Cox proportional hazard regression survival analysis including pretreatment ctDNA levels and other clinical indices.
Publication Date
1-1-2022
Publisher
figshare Academic Research System
DOI
10.6084/m9.figshare.21393919
Document Type
Data Set
Recommended Citation
Zhao, Dandan; Li, Miaomiao; Yang, Quanyu; Ma, Tonghui; Ye, Yingying; Wang, Dedao; Zhu, Jun; Cao, Jiaowu; Mi, Lan; Song, Yuqin; Qi, Fei; Zhu, Jianhua; Wang, Chunyang; Hu, Dingyao; Yu, Hui; Wang, Xiaojuan (2022), "Additional file 1 of Clinical implications of circulating tumor DNA in predicting the outcome of diffuse large B cell lymphoma patients receiving first-line therapy", figshare Academic Research System, doi: 10.6084/m9.figshare.21393919
https://doi.org/10.6084/m9.figshare.21393919
Identifier
10.6084/m9.figshare.21393919
Embargo Date
1-1-2022